First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
On Wednesday, the FDA approved Verona Pharma plc’s (NASDAQ:VRNA) Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvayre is ...
In this micro-activity, learners will engage with a 15-minute expert faculty podcast focused on the latest advancements in COPD management and novel therapeutics. Accompanying the podcast is an ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that UnitedHealthcare®, the largest commercial insurer in the United ...
In recent statements to the Financial Times and The Sunday Times, GSK plc GSK Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion (£1.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback